PUK12 A COST-UTILITY ANALYSIS OF SOLIFENACIN 5 MG AND 10 MGVERSUS FESOTERODINE 4 MG AND 8 MG IN THE PHARMACOLOGICAL TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER (OAB) IN THE UK NHS
2008 ◽
Vol 11
(6)
◽
pp. A653
◽
L Cardozo
◽
A Thorpe
◽
M Grishchenko
◽
MK Sidhu
2008 ◽
Vol 11
(6)
◽
pp. A653
◽
L Cardozo
◽
A Thorpe
◽
M Grishchenko
◽
MK Sidhu
2014 ◽
Vol 17
(7)
◽
pp. A641-A642
◽
T. Snowsill
◽
N. Huxley
◽
M. Hoyle
◽
L. Crathorne
◽
M. Haasova
◽
...
2007 ◽
Vol 22
(11)
◽
pp. 3355-3357
◽
J. A. Ray
◽
W. J. Valentine
◽
A. J. Palmer
V. K. Brennan
◽
F. Colaone
◽
S. Shergill
◽
R. F. Pollock
2019 ◽
Vol 22
◽
pp. S915-S916
Z. Karimi Majd
◽
S. Taheri
◽
N. Yousefi
◽
F. Peiravian
2004 ◽
Vol 7
(1-4)
◽
pp. 29-40
◽
Edit Remák
◽
John Hutton
◽
Caroline E Selai
◽
Michael R Trimble
◽
Martin J Price
2001 ◽
Vol 191
(1-2)
◽
pp. 95-102
◽
Manouche Tavakoli
◽
M Malek
2014 ◽
Vol 33
(8)
◽
pp. 1109-1117
◽
Maria Paola Bertapelle
◽
Mario Vottero
◽
Giulio Del Popolo
◽
Marco Mencarini
◽
Edoardo Ostardo
◽
...
2016 ◽
Vol 19
(10)
◽
pp. 995-1002
◽
Gorden Muduma
◽
Isaac Odeyemi
◽
Richard F. Pollock
2018 ◽
Vol 275
◽
pp. 434-443
◽
Ailsa J. McKay
◽
Helen Hogan
◽
Steve E. Humphries
◽
Dalya Marks
◽
Kausik K. Ray
◽
...
Close
Export Citation Format
Close
Share Document
Close